| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 5.64e-04 | 43 | 75 | 3 | GO:0030280 | |
| GeneOntologyMolecularFunction | miRNA binding | 7.80e-04 | 48 | 75 | 3 | GO:0035198 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 9.31e-04 | 51 | 75 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.16e-03 | 55 | 75 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.42e-03 | 15 | 75 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.49e-03 | 60 | 75 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 1.64e-03 | 62 | 75 | 3 | GO:0061980 | |
| GeneOntologyMolecularFunction | Hsp70 protein binding | 1.72e-03 | 63 | 75 | 3 | GO:0030544 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.72e-03 | 136 | 75 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | protein kinase activity | 1.82e-03 | 600 | 75 | 8 | GO:0004672 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.97e-03 | 66 | 75 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.97e-03 | 66 | 75 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.05e-03 | 18 | 75 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 3.06e-03 | 22 | 75 | 2 | GO:0004115 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 3.16e-03 | 78 | 75 | 3 | GO:0003725 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 3.16e-03 | 78 | 75 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 3.18e-03 | 807 | 75 | 9 | GO:0016788 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 3.28e-03 | 79 | 75 | 3 | GO:0004521 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 3.35e-03 | 23 | 75 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 3.64e-03 | 24 | 75 | 2 | GO:0047555 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.77e-03 | 83 | 75 | 3 | GO:1990841 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 3.95e-03 | 25 | 75 | 2 | GO:0004114 | |
| GeneOntologyBiologicalProcess | siRNA-mediated post-transcriptional gene silencing | 1.84e-07 | 4 | 75 | 3 | GO:0140766 | |
| GeneOntologyBiologicalProcess | siRNA-mediated gene silencing by mRNA destabilization | 1.84e-07 | 4 | 75 | 3 | GO:0090625 | |
| GeneOntologyBiologicalProcess | RNA secondary structure unwinding | 3.82e-06 | 9 | 75 | 3 | GO:0010501 | |
| GeneOntologyBiologicalProcess | RISC complex assembly | 5.44e-06 | 10 | 75 | 3 | GO:0070922 | |
| GeneOntologyBiologicalProcess | pre-miRNA processing | 3.03e-05 | 17 | 75 | 3 | GO:0031054 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 1.53e-04 | 74 | 75 | 4 | GO:0070918 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 1.86e-04 | 145 | 75 | 5 | GO:0001578 | |
| GeneOntologyBiologicalProcess | cilium assembly | 2.07e-04 | 444 | 75 | 8 | GO:0060271 | |
| GeneOntologyCellularComponent | RISC-loading complex | 5.44e-06 | 10 | 76 | 3 | GO:0070578 | |
| GeneOntologyCellularComponent | endoribonuclease complex | 9.73e-06 | 37 | 76 | 4 | GO:1902555 | |
| GeneOntologyCellularComponent | endonuclease complex | 1.79e-05 | 43 | 76 | 4 | GO:1905348 | |
| GeneOntologyCellularComponent | dynein complex | 4.44e-05 | 54 | 76 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.00e-04 | 25 | 76 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | supramolecular fiber | ANK3 KRT81 KRT83 SYNE1 KRT86 DNAH17 CAPN6 CMYA5 NEB GGPS1 DYNC1LI2 MX2 DNAH1 | 3.02e-04 | 1179 | 76 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | ANK3 KRT81 KRT83 SYNE1 KRT86 DNAH17 CAPN6 CMYA5 NEB GGPS1 DYNC1LI2 MX2 DNAH1 | 3.22e-04 | 1187 | 76 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | P-body | 5.24e-04 | 102 | 76 | 4 | GO:0000932 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | AGO2 AGO1 AGO4 BRCA2 KAT8 MARCHF6 ELP1 TSN FBXO39 CREBBP DYRK2 | 7.45e-04 | 972 | 76 | 11 | GO:0140535 |
| GeneOntologyCellularComponent | outer dynein arm | 8.41e-04 | 12 | 76 | 2 | GO:0036157 | |
| HumanPheno | Perifollicular hyperkeratosis | 1.29e-06 | 4 | 36 | 3 | HP:0007468 | |
| HumanPheno | Abnormal perifollicular morphology | 6.39e-06 | 6 | 36 | 3 | HP:0031285 | |
| Domain | Argonaute_N | 2.38e-07 | 4 | 74 | 3 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 2.38e-07 | 4 | 74 | 3 | IPR032473 | |
| Domain | ArgoL2 | 2.38e-07 | 4 | 74 | 3 | IPR032472 | |
| Domain | ArgoN | 2.38e-07 | 4 | 74 | 3 | PF16486 | |
| Domain | ArgoMid | 2.38e-07 | 4 | 74 | 3 | PF16487 | |
| Domain | ArgoL2 | 2.38e-07 | 4 | 74 | 3 | PF16488 | |
| Domain | DUF1785 | 5.94e-07 | 5 | 74 | 3 | SM01163 | |
| Domain | ArgoL1 | 1.18e-06 | 6 | 74 | 3 | PF08699 | |
| Domain | ArgoL1 | 1.18e-06 | 6 | 74 | 3 | IPR014811 | |
| Domain | PIWI | 3.30e-06 | 8 | 74 | 3 | PS50822 | |
| Domain | Piwi | 3.30e-06 | 8 | 74 | 3 | SM00950 | |
| Domain | Piwi | 3.30e-06 | 8 | 74 | 3 | IPR003165 | |
| Domain | Piwi | 3.30e-06 | 8 | 74 | 3 | PF02171 | |
| Domain | PAZ | 4.93e-06 | 9 | 74 | 3 | PS50821 | |
| Domain | PAZ | 4.93e-06 | 9 | 74 | 3 | SM00949 | |
| Domain | PAZ_dom | 4.93e-06 | 9 | 74 | 3 | IPR003100 | |
| Domain | PAZ | 4.93e-06 | 9 | 74 | 3 | PF02170 | |
| Domain | BROMODOMAIN_1 | 1.36e-05 | 37 | 74 | 4 | PS00633 | |
| Domain | Bromodomain | 1.51e-05 | 38 | 74 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 2.06e-05 | 41 | 74 | 4 | PS50014 | |
| Domain | BROMO | 2.27e-05 | 42 | 74 | 4 | SM00297 | |
| Domain | Bromodomain | 2.27e-05 | 42 | 74 | 4 | IPR001487 | |
| Domain | - | 2.27e-05 | 42 | 74 | 4 | 1.20.920.10 | |
| Domain | Keratin_2_head | 1.14e-04 | 24 | 74 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 1.14e-04 | 24 | 74 | 3 | PF16208 | |
| Domain | Keratin_II | 1.45e-04 | 26 | 74 | 3 | IPR003054 | |
| Domain | GAF | 3.21e-04 | 7 | 74 | 2 | PF01590 | |
| Domain | GAF | 4.27e-04 | 8 | 74 | 2 | IPR003018 | |
| Domain | GAF | 4.27e-04 | 8 | 74 | 2 | SM00065 | |
| Domain | PH_dom-spectrin-type | 5.48e-04 | 9 | 74 | 2 | IPR001605 | |
| Domain | GAF_dom-like | 5.48e-04 | 9 | 74 | 2 | IPR029016 | |
| Domain | - | 5.48e-04 | 9 | 74 | 2 | 3.30.450.40 | |
| Domain | - | 8.54e-04 | 47 | 74 | 3 | 3.30.420.10 | |
| Domain | G_DYNAMIN_dom | 1.37e-03 | 14 | 74 | 2 | IPR030381 | |
| Domain | CNH | 1.37e-03 | 14 | 74 | 2 | SM00036 | |
| Domain | G_DYNAMIN_2 | 1.37e-03 | 14 | 74 | 2 | PS51718 | |
| Domain | Dynamin_GTPase | 1.57e-03 | 15 | 74 | 2 | IPR001401 | |
| Domain | Dynamin_N | 1.57e-03 | 15 | 74 | 2 | PF00350 | |
| Domain | - | 1.57e-03 | 15 | 74 | 2 | 1.10.1000.11 | |
| Domain | CNH | 1.57e-03 | 15 | 74 | 2 | PF00780 | |
| Domain | Dynamin_SF | 1.57e-03 | 15 | 74 | 2 | IPR022812 | |
| Domain | Sec7 | 1.57e-03 | 15 | 74 | 2 | PF01369 | |
| Domain | CNH | 1.57e-03 | 15 | 74 | 2 | PS50219 | |
| Domain | CNH_dom | 1.57e-03 | 15 | 74 | 2 | IPR001180 | |
| Domain | Sec7_alpha_orthog | 1.57e-03 | 15 | 74 | 2 | IPR023394 | |
| Domain | Sec7 | 1.79e-03 | 16 | 74 | 2 | SM00222 | |
| Domain | SEC7 | 1.79e-03 | 16 | 74 | 2 | PS50190 | |
| Domain | Sec7_dom | 1.79e-03 | 16 | 74 | 2 | IPR000904 | |
| Domain | Intermediate_filament_CS | 2.00e-03 | 63 | 74 | 3 | IPR018039 | |
| Domain | PH | 2.15e-03 | 229 | 74 | 5 | PF00169 | |
| Domain | PDEase | 2.54e-03 | 19 | 74 | 2 | IPR023088 | |
| Domain | RNaseH-like_dom | 2.59e-03 | 69 | 74 | 3 | IPR012337 | |
| Domain | RCC1 | 2.81e-03 | 20 | 74 | 2 | PF00415 | |
| Domain | Filament | 2.81e-03 | 71 | 74 | 3 | SM01391 | |
| Domain | IF | 2.93e-03 | 72 | 74 | 3 | PS00226 | |
| Domain | Filament | 3.04e-03 | 73 | 74 | 3 | PF00038 | |
| Domain | PDEase_I | 3.10e-03 | 21 | 74 | 2 | PF00233 | |
| Domain | RCC1_1 | 3.10e-03 | 21 | 74 | 2 | PS00625 | |
| Domain | RCC1_2 | 3.10e-03 | 21 | 74 | 2 | PS00626 | |
| Domain | RCC1_3 | 3.10e-03 | 21 | 74 | 2 | PS50012 | |
| Domain | PDEASE_I | 3.10e-03 | 21 | 74 | 2 | PS00126 | |
| Domain | PDEase_CS | 3.10e-03 | 21 | 74 | 2 | IPR023174 | |
| Domain | Reg_chr_condens | 3.40e-03 | 22 | 74 | 2 | IPR000408 | |
| Domain | - | 3.40e-03 | 22 | 74 | 2 | 2.130.10.30 | |
| Domain | - | 3.40e-03 | 22 | 74 | 2 | 1.10.1300.10 | |
| Domain | IF | 3.41e-03 | 76 | 74 | 3 | IPR001664 | |
| Domain | PDEase_catalytic_dom | 3.71e-03 | 23 | 74 | 2 | IPR002073 | |
| Domain | RCC1/BLIP-II | 3.71e-03 | 23 | 74 | 2 | IPR009091 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 2.19e-08 | 8 | 61 | 4 | MM15082 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 3.93e-08 | 9 | 61 | 4 | M27340 | |
| Pathway | BIOCARTA_DICER_PATHWAY | 7.66e-07 | 5 | 61 | 3 | M22079 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 1.53e-06 | 6 | 61 | 3 | MM14818 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.53e-06 | 6 | 61 | 3 | MM15083 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 2.67e-06 | 7 | 61 | 3 | M46421 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 6.36e-06 | 9 | 61 | 3 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 6.36e-06 | 9 | 61 | 3 | M46436 | |
| Pathway | REACTOME_CA2_PATHWAY | 6.87e-06 | 62 | 61 | 5 | M27321 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 9.05e-06 | 10 | 61 | 3 | M48013 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 1.34e-05 | 34 | 61 | 4 | M46422 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 2.14e-05 | 13 | 61 | 3 | M46434 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 5.02e-05 | 17 | 61 | 3 | M27788 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 5.81e-05 | 49 | 61 | 4 | MM14837 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 7.11e-05 | 19 | 61 | 3 | M48238 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 1.51e-04 | 360 | 61 | 8 | M27267 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 1.66e-04 | 25 | 61 | 3 | M712 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 2.34e-04 | 28 | 61 | 3 | M48253 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 3.10e-04 | 137 | 61 | 5 | M48232 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 3.50e-04 | 32 | 61 | 3 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 3.50e-04 | 32 | 61 | 3 | M27900 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 3.66e-04 | 220 | 61 | 6 | M27794 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 4.15e-04 | 146 | 61 | 5 | M27288 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 4.56e-04 | 149 | 61 | 5 | M27888 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER | 4.57e-04 | 35 | 61 | 3 | M42525 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 4.73e-04 | 84 | 61 | 4 | M27495 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 5.39e-04 | 37 | 61 | 3 | M29790 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 6.95e-04 | 93 | 61 | 4 | M42521 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 7.31e-04 | 41 | 61 | 3 | M29748 | |
| Pathway | BIOCARTA_RHODOPSIN_PATHWAY | 9.88e-04 | 11 | 61 | 2 | M22044 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE | 9.88e-04 | 11 | 61 | 2 | M27180 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.09e-03 | 47 | 61 | 3 | M29777 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 1.23e-03 | 49 | 61 | 3 | M48250 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.72e-03 | 296 | 61 | 6 | M27869 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.74e-03 | 119 | 61 | 4 | M607 | |
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 1.00e-08 | 3 | 76 | 3 | 25557232 | |
| Pubmed | Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins. | 1.00e-08 | 3 | 76 | 3 | 19946268 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 1.00e-08 | 3 | 76 | 3 | 1372089 | |
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 1712823 | ||
| Pubmed | Molecular dissection of human Argonaute proteins by DNA shuffling. | 4.00e-08 | 4 | 76 | 3 | 23748378 | |
| Pubmed | Slicing-independent RISC activation requires the argonaute PAZ domain. | 4.00e-08 | 4 | 76 | 3 | 22795694 | |
| Pubmed | Importance of translation and nonnucleolytic ago proteins for on-target RNA interference. | 4.00e-08 | 4 | 76 | 3 | 18771919 | |
| Pubmed | Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. | 4.00e-08 | 4 | 76 | 3 | 15260970 | |
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 15797458 | ||
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 19966796 | ||
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 19393748 | ||
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 12414724 | ||
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 19324964 | ||
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 12526743 | ||
| Pubmed | Differential expression of components of the microRNA machinery during mouse organogenesis. | 1.00e-07 | 5 | 76 | 3 | 16036130 | |
| Pubmed | 3.49e-07 | 7 | 76 | 3 | 34907157 | ||
| Pubmed | 3.49e-07 | 7 | 76 | 3 | 19536157 | ||
| Pubmed | 3.49e-07 | 7 | 76 | 3 | 19383768 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 3.49e-07 | 7 | 76 | 3 | 19470757 | |
| Pubmed | Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis. | 5.57e-07 | 8 | 76 | 3 | 19345100 | |
| Pubmed | 5.57e-07 | 8 | 76 | 3 | 29021386 | ||
| Pubmed | Identification of eight members of the Argonaute family in the human genome. | 8.34e-07 | 9 | 76 | 3 | 12906857 | |
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 2.17e-06 | 12 | 76 | 3 | 10692104 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23603119 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 26242502 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 33233493 | ||
| Pubmed | A missense mutation in the type II hair keratin hHb3 is associated with monilethrix. | 4.71e-06 | 2 | 76 | 2 | 15744029 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 1847109 | ||
| Pubmed | Structural disease progression in PDE6-associated autosomal recessive retinitis pigmentosa. | 4.71e-06 | 2 | 76 | 2 | 30153077 | |
| Pubmed | Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. | 4.71e-06 | 2 | 76 | 2 | 16936728 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10534406 | ||
| Pubmed | Argonaute Family Protein Expression in Normal Tissue and Cancer Entities. | 4.71e-06 | 2 | 76 | 2 | 27518285 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21410772 | ||
| Pubmed | Association of Polymorphic Variants in Argonaute Genes with Depression Risk in a Polish Population. | 4.71e-06 | 2 | 76 | 2 | 36142498 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 9665406 | ||
| Pubmed | Polymorphisms and expression of genes encoding Argonautes 1 and 2 in autoimmune thyroid diseases. | 4.71e-06 | 2 | 76 | 2 | 29256262 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 1326553 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 9402962 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 35033039 | ||
| Pubmed | Argonaute proteins couple chromatin silencing to alternative splicing. | 4.71e-06 | 2 | 76 | 2 | 22961379 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23864662 | ||
| Pubmed | Rod phosphodiesterase-6 PDE6A and PDE6B subunits are enzymatically equivalent. | 4.71e-06 | 2 | 76 | 2 | 20940301 | |
| Pubmed | Association study of AGO1 and AGO2 genes polymorphisms with recurrent pregnancy loss. | 4.71e-06 | 2 | 76 | 2 | 31666609 | |
| Pubmed | Alternative RISC assembly: binding and repression of microRNA-mRNA duplexes by human Ago proteins. | 4.71e-06 | 2 | 76 | 2 | 23019594 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 2165490 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 34170501 | ||
| Pubmed | Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. | 4.71e-06 | 2 | 76 | 2 | 22858679 | |
| Pubmed | Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. | 4.71e-06 | 2 | 76 | 2 | 12230974 | |
| Pubmed | Effects of Echinococcus multilocularis miR-71 mimics on murine macrophage RAW264.7 cells. | 4.71e-06 | 2 | 76 | 2 | 26995025 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19723326 | ||
| Pubmed | Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma. | 4.71e-06 | 2 | 76 | 2 | 23696926 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21846468 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31724726 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30998820 | ||
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 5.50e-06 | 16 | 76 | 3 | 15085952 | |
| Pubmed | Tooth morphogenesis and ameloblast differentiation are regulated by micro-RNAs. | 5.50e-06 | 16 | 76 | 3 | 20102707 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 8.59e-06 | 218 | 76 | 6 | 33378226 | |
| Pubmed | PERP regulates enamel formation via effects on cell-cell adhesion and gene expression. | 9.47e-06 | 19 | 76 | 3 | 21285247 | |
| Pubmed | Turning catalytically inactive human Argonaute proteins into active slicer enzymes. | 1.41e-05 | 3 | 76 | 2 | 23665583 | |
| Pubmed | The roles of individual mammalian argonautes in RNA interference in vivo. | 1.41e-05 | 3 | 76 | 2 | 24992693 | |
| Pubmed | New mouse models for recessive retinitis pigmentosa caused by mutations in the Pde6a gene. | 1.41e-05 | 3 | 76 | 2 | 18849587 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 21552258 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24086155 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 15284456 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 30201950 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 2167232 | ||
| Pubmed | Cyclic GMP-activated conductance of retinal photoreceptor cells. | 1.41e-05 | 3 | 76 | 2 | 2467600 | |
| Pubmed | A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. | 1.41e-05 | 3 | 76 | 2 | 17626790 | |
| Pubmed | Sequence data and chromosomal localization of human type I and type II hair keratin genes. | 1.41e-05 | 3 | 76 | 2 | 7556444 | |
| Pubmed | Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. | 1.41e-05 | 3 | 76 | 2 | 15908945 | |
| Pubmed | Sequences and differential expression of three novel human type-II hair keratins. | 1.41e-05 | 3 | 76 | 2 | 9084137 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 10373499 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24394593 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 17891150 | ||
| Pubmed | 2.22e-05 | 153 | 76 | 5 | 10718198 | ||
| Pubmed | 2.27e-05 | 75 | 76 | 4 | 25593309 | ||
| Pubmed | DMGDH COL12A1 CLIC5 ANK3 KAT8 ELP1 TSN MGLL NEB ATAD2 HYDIN EHD4 | 2.28e-05 | 1293 | 76 | 12 | 15342556 | |
| Pubmed | 2.51e-05 | 26 | 76 | 3 | 19898466 | ||
| Pubmed | 2.64e-05 | 266 | 76 | 6 | 19380743 | ||
| Pubmed | Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. | 2.82e-05 | 4 | 76 | 2 | 20671708 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 21948796 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 16289642 | ||
| Pubmed | MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. | 2.82e-05 | 4 | 76 | 2 | 15937477 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 8094988 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 23110154 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 19758987 | ||
| Pubmed | Argonaute proteins: potential biomarkers for human colon cancer. | 2.82e-05 | 4 | 76 | 2 | 20146808 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 37934199 | ||
| Pubmed | Thymine DNA glycosylase is a positive regulator of Wnt signaling in colorectal cancer. | 2.82e-05 | 4 | 76 | 2 | 24532795 | |
| Pubmed | Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma. | 2.82e-05 | 4 | 76 | 2 | 22647351 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 23033484 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 19578754 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 21799013 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 9457912 | ||
| Pubmed | Mammalian microtubule P-body dynamics are mediated by nesprin-1. | 2.82e-05 | 4 | 76 | 2 | 24862572 | |
| Pubmed | Genetic Rescue Reverses Microglial Activation in Preclinical Models of Retinitis Pigmentosa. | 2.82e-05 | 4 | 76 | 2 | 30001913 | |
| Pubmed | A Requirement for Argonaute 4 in Mammalian Antiviral Defense. | 2.82e-05 | 4 | 76 | 2 | 32049003 | |
| Pubmed | MxA interacts with and is modified by the SUMOylation machinery. | 2.82e-05 | 27 | 76 | 3 | 25447205 | |
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 17656371 | ||
| Pubmed | Quantitative functions of Argonaute proteins in mammalian development. | 4.69e-05 | 5 | 76 | 2 | 22474261 | |
| Cytoband | 12q13 | 2.30e-04 | 71 | 76 | 3 | 12q13 | |
| GeneFamily | Argonaute/PIWI family | 1.32e-06 | 8 | 53 | 3 | 408 | |
| GeneFamily | Keratins, type II | 6.62e-05 | 27 | 53 | 3 | 609 | |
| GeneFamily | Dyneins, axonemal | 1.11e-03 | 17 | 53 | 2 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.11e-03 | 17 | 53 | 2 | 486 | |
| GeneFamily | Phosphodiesterases | 2.23e-03 | 24 | 53 | 2 | 681 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.10e-03 | 206 | 53 | 4 | 682 | |
| Coexpression | HUPER_BREAST_BASAL_VS_LUMINAL_DN | 2.46e-05 | 58 | 76 | 4 | M5505 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 2.50e-05 | 199 | 76 | 6 | M3417 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.50e-05 | 199 | 76 | 6 | M9180 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 2.50e-05 | 199 | 76 | 6 | M3070 | |
| Coexpression | GSE10325_CD4_TCELL_VS_MYELOID_UP | 2.50e-05 | 199 | 76 | 6 | M3078 | |
| Coexpression | GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN | 2.57e-05 | 200 | 76 | 6 | M3222 | |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN | 4.54e-05 | 24 | 76 | 3 | M19520 | |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_PROJECTION_NEURONS | 6.95e-05 | 147 | 76 | 5 | MM414 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 1.71e-04 | 178 | 76 | 5 | M17079 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 1.94e-04 | 183 | 76 | 5 | M2993 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP | 1.99e-04 | 290 | 76 | 6 | M11616 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 2.14e-04 | 294 | 76 | 6 | M41112 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP | 2.31e-04 | 190 | 76 | 5 | M18436 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 2.66e-04 | 434 | 76 | 7 | M15150 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN | 2.67e-04 | 196 | 76 | 5 | M8717 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP | 2.80e-04 | 198 | 76 | 5 | M5293 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN | 2.86e-04 | 199 | 76 | 5 | M4620 | |
| Coexpression | GSE360_DC_VS_MAC_T_GONDII_DN | 2.86e-04 | 199 | 76 | 5 | M5184 | |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP | 2.86e-04 | 199 | 76 | 5 | M9269 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN | 2.86e-04 | 199 | 76 | 5 | M5707 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP | 2.86e-04 | 199 | 76 | 5 | M6970 | |
| Coexpression | GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN | 2.93e-04 | 200 | 76 | 5 | M7799 | |
| Coexpression | GSE13229_IMM_VS_MATURE_NKCELL_UP | 2.93e-04 | 200 | 76 | 5 | M3205 | |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP | 2.93e-04 | 200 | 76 | 5 | M6606 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN | 2.93e-04 | 200 | 76 | 5 | M9597 | |
| Coexpression | GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN | 2.93e-04 | 200 | 76 | 5 | M6570 | |
| Coexpression | GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 2.93e-04 | 200 | 76 | 5 | M6563 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 2.93e-04 | 200 | 76 | 5 | M9889 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN | 2.93e-04 | 200 | 76 | 5 | M8427 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN | 2.93e-04 | 200 | 76 | 5 | M6789 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN | 2.93e-04 | 200 | 76 | 5 | M9837 | |
| Coexpression | GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP | 2.93e-04 | 200 | 76 | 5 | M9203 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP | 2.93e-04 | 200 | 76 | 5 | M6035 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 3.22e-04 | 448 | 76 | 7 | MM1044 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-07 | 104 | 76 | 5 | a4ae3cae44aac8b6e0d14896f9acab44f0cc97c4 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.17e-06 | 199 | 76 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.62e-06 | 166 | 76 | 5 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.02e-05 | 168 | 76 | 5 | 8ade4d098aeecda2d80c1cad1cebe9a063eae948 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 169 | 76 | 5 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | FLU-Healthy-0|FLU / Virus stimulation, Condition and Cluster | 1.54e-05 | 183 | 76 | 5 | 058604ddb06b3bef131183d86b83b422dae8f6cb | |
| ToppCell | FLU-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 1.54e-05 | 183 | 76 | 5 | 7a6f18246c39864479e114f698581f667fa9c600 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 184 | 76 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-05 | 184 | 76 | 5 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 184 | 76 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 184 | 76 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 186 | 76 | 5 | 26458ff8cad5577de4306cffa0ca69eb26940e0d | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 186 | 76 | 5 | a71397efc68d2916ddc373d92cfd07be58033e1c | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-05 | 187 | 76 | 5 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-05 | 190 | 76 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-05 | 190 | 76 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-05 | 191 | 76 | 5 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.99e-05 | 193 | 76 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.04e-05 | 194 | 76 | 5 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.04e-05 | 194 | 76 | 5 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.09e-05 | 195 | 76 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.09e-05 | 195 | 76 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.09e-05 | 195 | 76 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-05 | 195 | 76 | 5 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.14e-05 | 196 | 76 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.20e-05 | 197 | 76 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-05 | 197 | 76 | 5 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.20e-05 | 197 | 76 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.20e-05 | 197 | 76 | 5 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.20e-05 | 197 | 76 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.20e-05 | 197 | 76 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.20e-05 | 197 | 76 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.25e-05 | 198 | 76 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 2.25e-05 | 198 | 76 | 5 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 199 | 76 | 5 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 199 | 76 | 5 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.36e-05 | 200 | 76 | 5 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.36e-05 | 200 | 76 | 5 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-04 | 153 | 76 | 4 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.47e-04 | 156 | 76 | 4 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.51e-04 | 157 | 76 | 4 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 158 | 76 | 4 | 74aa4f75307575ac3b2b1aa9f727753692f88742 | |
| ToppCell | Severe-Lymphoid-NK-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 1.62e-04 | 160 | 76 | 4 | cb2276d9bd78508644420e9580d3c17b914224cb | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 160 | 76 | 4 | 5cc1b75e3c20d83112b3aa2f3c749a6c73910a2d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-04 | 162 | 76 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 162 | 76 | 4 | 76e289ad9fd3694f77fd0d19e74c1cb8e87b8094 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 163 | 76 | 4 | e6213900f56257fe38ac7852351bea0340294be0 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 163 | 76 | 4 | ed7319185c1ec384444309bb8be95691a0c2091c | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 163 | 76 | 4 | ef35d7ff09aa364734fea7fdaab6260c0a3fbf09 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-04 | 169 | 76 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.04e-04 | 170 | 76 | 4 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 171 | 76 | 4 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.09e-04 | 171 | 76 | 4 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 171 | 76 | 4 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.09e-04 | 171 | 76 | 4 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 172 | 76 | 4 | f3c16a62eba1ed190318beee131c71c5150b266a | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-04 | 172 | 76 | 4 | 6379ae0aca9007c3a8a87e3330908fc90961ad3f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-04 | 172 | 76 | 4 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-04 | 172 | 76 | 4 | 490745024730df6357f6c2b81d7a64e21557c0d5 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 173 | 76 | 4 | f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.18e-04 | 173 | 76 | 4 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.18e-04 | 173 | 76 | 4 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.18e-04 | 173 | 76 | 4 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.18e-04 | 173 | 76 | 4 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.18e-04 | 173 | 76 | 4 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.18e-04 | 173 | 76 | 4 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-04 | 176 | 76 | 4 | 269326c2bf44a9003d95bc6dbc839f08f25737ca | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-04 | 176 | 76 | 4 | 238244294d08975df6bfa26b2b437db3654408ae | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-04 | 177 | 76 | 4 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-04 | 177 | 76 | 4 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | Severe_COVID-19-Myeloid-Neutrophil|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.38e-04 | 177 | 76 | 4 | a6fae376f1beb1df423484d9b1bd1d954ca117af | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 2.38e-04 | 177 | 76 | 4 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.38e-04 | 177 | 76 | 4 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.38e-04 | 177 | 76 | 4 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-04 | 177 | 76 | 4 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 178 | 76 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 2.43e-04 | 178 | 76 | 4 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.49e-04 | 179 | 76 | 4 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 179 | 76 | 4 | 30efe1f0394c0edb27b91890b5c4637b73cbc5ec | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-04 | 179 | 76 | 4 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 2.49e-04 | 179 | 76 | 4 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-04 | 179 | 76 | 4 | dd3cf8fd10dc257d933a7f45860dc2e244c158b7 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-04 | 180 | 76 | 4 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-04 | 180 | 76 | 4 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.54e-04 | 180 | 76 | 4 | 27672ac6a02172a31851f18decb9acffa8f5a703 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages|bone_marrow / Manually curated celltypes from each tissue | 2.54e-04 | 180 | 76 | 4 | daf69a548ed7c6f285a6adcff00f99aa22f9d6a5 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.54e-04 | 180 | 76 | 4 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.59e-04 | 181 | 76 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-04 | 181 | 76 | 4 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-04 | 181 | 76 | 4 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.65e-04 | 182 | 76 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 182 | 76 | 4 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.65e-04 | 182 | 76 | 4 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-04 | 182 | 76 | 4 | 57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.65e-04 | 182 | 76 | 4 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 182 | 76 | 4 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.65e-04 | 182 | 76 | 4 | 6bd48c5d60a259719f65cacee4b8135247e78fa9 | |
| ToppCell | URO-Lymphocyte-T_NK-dnT|URO / Disease, Lineage and Cell Type | 2.65e-04 | 182 | 76 | 4 | f2b1c524301d0f2d1b69c46f3653fd53c21c3aa0 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 2.70e-04 | 183 | 76 | 4 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.70e-04 | 183 | 76 | 4 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| Drug | AC1L1BIT | 1.72e-06 | 60 | 76 | 5 | CID000001457 | |
| Drug | trioxane | 9.98e-06 | 13 | 76 | 3 | CID000008081 | |
| Drug | melicopicine | 1.10e-05 | 2 | 76 | 2 | CID000101253 | |
| Drug | tebuquine | 1.10e-05 | 2 | 76 | 2 | CID000071991 | |
| Drug | 3,5-di-O-galloylquinic acid | 1.10e-05 | 2 | 76 | 2 | CID000460896 | |
| Drug | 4-hydroxy-2-nonenal | AGO2 CSF1R RBL1 DBF4 KAT8 PON1 ELP1 HERC3 FBXO39 CREBBP ARID5A MX2 | 1.25e-05 | 798 | 76 | 12 | ctd:C027576 |
| Drug | musk xylene | 2.35e-05 | 17 | 76 | 3 | CID000062329 | |
| Drug | ATBI | 2.81e-05 | 18 | 76 | 3 | CID000505862 | |
| Drug | sulfonamide-3 | 3.29e-05 | 3 | 76 | 2 | CID009847197 | |
| Drug | cycloguanil | 3.91e-05 | 20 | 76 | 3 | CID000009048 | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 5088_UP | |
| Drug | PF-00539745-00 [351321-33-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.14e-05 | 197 | 76 | 6 | 5974_UP | |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 5.14e-05 | 197 | 76 | 6 | 3514_UP | |
| Drug | Minoxidil [38304-91-5]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 5.14e-05 | 197 | 76 | 6 | 4800_UP | |
| Drug | Brinzolamide [138890-62-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 5.44e-05 | 199 | 76 | 6 | 3230_UP | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 5.59e-05 | 200 | 76 | 6 | 5521_UP | |
| Drug | pyriproxyfen | 6.03e-05 | 23 | 76 | 3 | CID000091753 | |
| Drug | AC1L2K1Q | 6.03e-05 | 23 | 76 | 3 | CID000022258 | |
| Drug | Lactupicrin | 6.57e-05 | 4 | 76 | 2 | CID000174880 | |
| Drug | lactucin | 6.57e-05 | 4 | 76 | 2 | CID000442266 | |
| Drug | salsalate | 7.06e-05 | 66 | 76 | 4 | CID000005161 | |
| Drug | homocysteine thiolactone | 7.78e-05 | 131 | 76 | 5 | CID000107712 | |
| Drug | p-aminophenol | 7.94e-05 | 68 | 76 | 4 | CID000000403 | |
| Disease | Beaded hair | 1.64e-08 | 3 | 76 | 3 | cv:C0546966 | |
| Disease | MONILETHRIX | 1.64e-08 | 3 | 76 | 3 | 158000 | |
| Disease | monilethrix (is_implicated_in) | 1.64e-08 | 3 | 76 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Monilethrix | 6.56e-08 | 4 | 76 | 3 | C0546966 | |
| Disease | hair disease (is_implicated_in) | 6.55e-06 | 2 | 76 | 2 | DOID:421 (is_implicated_in) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.15e-05 | 195 | 76 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Schizophrenia | TNIK ANK3 CYP2E1 VPS39 KAT8 PSD3 PON1 CMYA5 MAP2K7 ENO2 SYNGAP1 | 1.57e-05 | 883 | 76 | 11 | C0036341 |
| Disease | pyridoxamine measurement | 1.96e-05 | 3 | 76 | 2 | EFO_0021837 | |
| Disease | MEDULLOBLASTOMA | 9.75e-05 | 6 | 76 | 2 | 155255 | |
| Disease | Medulloblastoma | 9.75e-05 | 6 | 76 | 2 | cv:C0025149 | |
| Disease | colorectal carcinoma (is_marker_for) | 1.20e-04 | 37 | 76 | 3 | DOID:0080199 (is_marker_for) | |
| Disease | infertility (implicated_via_orthology) | 1.36e-04 | 7 | 76 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | dual specificity protein phosphatase 13 isoform A measurement | 1.81e-04 | 8 | 76 | 2 | EFO_0801549 | |
| Disease | Parkinson disease | 1.82e-04 | 321 | 76 | 6 | MONDO_0005180 | |
| Disease | Glioma | 2.33e-04 | 9 | 76 | 2 | cv:C0017638 | |
| Disease | medulloblastoma (is_implicated_in) | 2.91e-04 | 10 | 76 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | 4.11e-04 | 525 | 76 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.11e-04 | 525 | 76 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 4.21e-04 | 527 | 76 | 7 | C1458155 | |
| Disease | Hematologic Neoplasms | 4.25e-04 | 12 | 76 | 2 | C0376545 | |
| Disease | Breast Carcinoma | 4.76e-04 | 538 | 76 | 7 | C0678222 | |
| Disease | plasma beta-amyloid 1-42 measurement | 5.01e-04 | 13 | 76 | 2 | EFO_0005660 | |
| Disease | asthma, response to diisocyanate | 5.77e-04 | 261 | 76 | 5 | EFO_0006995, MONDO_0004979 | |
| Disease | Lung Neoplasms | 6.18e-04 | 265 | 76 | 5 | C0024121 | |
| Disease | Malignant neoplasm of lung | 6.29e-04 | 266 | 76 | 5 | C0242379 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 6.73e-04 | 15 | 76 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | schizophrenia (implicated_via_orthology) | 7.30e-04 | 68 | 76 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 9.67e-04 | 169 | 76 | 4 | DOID:3908 (is_marker_for) | |
| Disease | Intellectual Disability | 1.04e-03 | 447 | 76 | 6 | C3714756 | |
| Disease | Prostatic Neoplasms | 1.05e-03 | 616 | 76 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.05e-03 | 616 | 76 | 7 | C0376358 | |
| Disease | sex interaction measurement, bilirubin measurement | 1.46e-03 | 22 | 76 | 2 | EFO_0004570, EFO_0008343 | |
| Disease | malignant astrocytoma (is_marker_for) | 1.60e-03 | 23 | 76 | 2 | DOID:3069 (is_marker_for) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 2.04e-03 | 26 | 76 | 2 | DOID:234 (is_implicated_in) | |
| Disease | Micronuclei, Chromosome-Defective | 2.04e-03 | 26 | 76 | 2 | C1449861 | |
| Disease | Micronuclei, Genotoxicant-Induced | 2.04e-03 | 26 | 76 | 2 | C1449862 | |
| Disease | mean corpuscular hemoglobin concentration | 2.11e-03 | 1105 | 76 | 9 | EFO_0004528 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.20e-03 | 27 | 76 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | prostate carcinoma in situ (is_marker_for) | 2.37e-03 | 28 | 76 | 2 | DOID:8634 (is_marker_for) | |
| Disease | bipolar disorder (is_implicated_in) | 2.54e-03 | 29 | 76 | 2 | DOID:3312 (is_implicated_in) | |
| Disease | selenium measurement | 2.54e-03 | 29 | 76 | 2 | EFO_0006331 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RAQDKVHYYIKLKDL | 281 | Q13569 | |
| KIYKAVEKLGAYELV | 91 | Q03989 | |
| LKKEKLEYTPGEHEY | 2011 | Q9NR48 | |
| DKHLYEEYVEKPLKL | 11 | Q9NPI1 | |
| KIKGIHDEKYVELFI | 191 | Q9H2U9 | |
| VTVISLLVYKKHKEY | 511 | Q14956 | |
| DIPKIDVYHYEVDIK | 46 | Q9UL18 | |
| YHLLAEKIYKIQKEL | 651 | Q92793 | |
| HEILIGYLEYVKKLG | 1451 | Q92793 | |
| SKIDLHKYLTVKDYL | 1036 | Q6PL18 | |
| KIDVYHYDVDIKPEK | 41 | Q9HCK5 | |
| HIDDIRYYIEQKKKE | 171 | Q9UBU7 | |
| LHVVKIVAKKYRNYD | 351 | Q9NZA1 | |
| AEVYHTLKGVIKDKY | 186 | P09104 | |
| KIDIYHYELDIKPEK | 51 | Q9UKV8 | |
| YLHSGKIVYRDLKLE | 261 | Q9Y243 | |
| DGKYIYAHKVLLKIR | 401 | O95199 | |
| HGYKAVKEALLDYKD | 81 | P05181 | |
| VDTKKYKVLLTYDTH | 386 | P25092 | |
| EDEKKGEKIYLYTHL | 281 | O60268 | |
| LHVLVVKEYEMAIYK | 1571 | Q4ZG55 | |
| LKIYEGAYHVLHKEL | 261 | Q99685 | |
| KLYKVNLKVKHVEYD | 596 | Q15034 | |
| VKYVDKIHIGNYEID | 176 | Q9H7Z6 | |
| VLEGYKKKYEEEVSL | 186 | O43790 | |
| EEKNLDLLYKYIVHK | 276 | O43237 | |
| KDAVEALYKVHGIEY | 351 | Q8WXQ8 | |
| IVKALYYLKEKHGVI | 226 | O14733 | |
| YYLKEKHGVIHRDVK | 231 | O14733 | |
| YKVIDYILHGKEDIK | 316 | P16499 | |
| IVFYKVIDYVLHGKE | 311 | P35913 | |
| YVKKFGRYLEHLEVK | 81 | Q8N4B4 | |
| VIKLLQSKYHYKEEA | 31 | Q8TBE9 | |
| KRLYEHIKNDKYLVG | 871 | O60337 | |
| HLKVEEYITPEKFKY | 316 | O43766 | |
| IDKYLKRYEKAIGHL | 936 | O95163 | |
| LAKVHAYIISYLKKE | 306 | Q9H223 | |
| IDIKKYCVHYLEDVG | 241 | O95749 | |
| GVLDYDEEKKLYLVH | 306 | Q9P2D7 | |
| GVDYKNIHLEKKYVR | 696 | P07333 | |
| YIYITEENKPHVKAK | 3541 | Q4G0P3 | |
| ELETLYKKAVKYVHS | 376 | Q9P2K1 | |
| IYAIHDETSYKGKKI | 591 | P51587 | |
| KIYIDCYEIIEKDIK | 2661 | Q99715 | |
| YIKIGDKEVEYHPKF | 3511 | Q9UFH2 | |
| KESKYEHGYLKALII | 581 | Q9P2H0 | |
| LGLIYLEEKEYEKAK | 1006 | Q5T0N1 | |
| GYVIKEIHYRKGKDA | 251 | Q8N3K9 | |
| LGDYMKYIHKKEIDL | 296 | Q5VUJ5 | |
| KKVLYREYVVKEGDH | 2926 | Q12955 | |
| KKIHYDSIKLYEKLE | 106 | Q9UI17 | |
| YEIHHGKKILYDILA | 431 | Q8IXB1 | |
| ELVEEKYKLFGELYK | 206 | Q9Y6Q1 | |
| DHVAYRYEVLKVIGK | 216 | Q92630 | |
| VLEGYKKKYEEEVAL | 191 | P78385 | |
| TLYKVLLDYIGHVKD | 106 | Q8TBZ9 | |
| DGKYVYIAELLAHKI | 231 | P27169 | |
| IHEYLQKYKGFKIDI | 6946 | Q8NF91 | |
| KYHEKAADKGVYIIG | 136 | Q8NBX0 | |
| VEAKGIKEHYFKPYI | 261 | P28749 | |
| EYLKHIMEVHKEKGY | 1006 | P57071 | |
| KTEDREGKKYIVAYH | 221 | Q96PZ0 | |
| KVKRYIIEHIDLGAY | 471 | Q9P2F8 | |
| EKRKLKSDHTDVLYY | 51 | Q5T5J6 | |
| KDGYKHIHYIKDTVE | 371 | Q12884 | |
| KLLLKYSFHDVKDYI | 4136 | Q63HN8 | |
| LEGCIHYKVVKYERI | 1141 | Q9UKE5 | |
| HYKVVKYERIKFLVI | 1146 | Q9UKE5 | |
| KEAIGFYEPIVKKHY | 476 | Q8N4P2 | |
| LGKEIEEYIHKPKYC | 636 | P42285 | |
| AHIEREEYKLKEYSK | 1171 | Q96PV0 | |
| IKSKEAEEYRLKEHY | 686 | Q9BQI7 | |
| IHLQKGKEYYIEILL | 451 | Q86WI1 | |
| VRLYHVYEKGKDLVV | 251 | O15195 | |
| KEAIGFYEPIVKKHY | 476 | Q86WT1 | |
| KLVDLYYQEKKHLEV | 121 | Q6PGP7 | |
| EYKLKDHYLEFEKTR | 966 | Q9NYI0 | |
| LKKAHKYSELIILYE | 496 | Q96JC1 | |
| KYSELIILYEKKGLH | 501 | Q96JC1 | |
| DGLKYDVKKVEEVVY | 196 | Q15631 | |
| VLEGYKKKYEEEVSL | 186 | Q14533 | |
| IHEEVEKYEKQYRGK | 476 | P20592 | |
| EARYKDLYVKDVLGH | 666 | P20929 |